Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager-Reference-Cited by-同舟云学术

Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager

Published:2024-02-20 Issue:5 Volume:8 Page:513-528
ISSN:2157-846X
Container-title:Nature Biomedical Engineering
language:en
Short-container-title:Nat. Biomed. Eng

Author:

Gong Ningqiang^ORCID,Han Xuexiang^ORCID,Xue Lulu^ORCID,Billingsley Margaret M.,Huang Xisha,El-Mayta Rakan^ORCID,Qin Jingya,Sheppard Neil C.^ORCID,June Carl H.,Mitchell Michael J.^ORCID

Funder

National Science Foundation

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41551-023-01147-6.pdf

Reference59 articles.

1. Huehls, A. M., Coupet, T. A. & Sentman, C. L. Bispecific T‐cell engagers for cancer immunotherapy. Immunol. Cell Biol. 93, 290–296 (2015).

2. Rader, C. Bispecific antibodies in cancer immunotherapy. Curr. Opin. Biotechnol. 65, 9–16 (2020).

3. Weidanz, J. Targeting cancer with bispecific antibodies. Science 371, 996–997 (2021).

4. de Miguel, M., Umana, P., de Morais, A. L. G., Moreno, V. & Calvo, E. T-cell-engaging therapy for solid tumors. Clin. Cancer Res. 27, 1595–1603 (2021).

5. Tian, Z., Liu, M., Zhang, Y. & Wang, X. Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies. J. Hematol. Oncol. 14, 1–18 (2021).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy;Nature Communications;2024-08-23

2. Synthesis and Activity of T-Cell Tumor-Directing MegaMolecules;Journal of the American Chemical Society;2024-08-21

3. Author Correction: Small-molecule-mediated control of the anti-tumour activity and off-tumour toxicity of a supramolecular bispecific T cell engager;Nature Biomedical Engineering;2024-03-15